Platform integrates yeast-based synthetic biology and robotics to streamline antibody discovery, eliminating lengthy steps and significantly reducing costs compared to traditional CRO outsourcing LONG ISLAND CITY, N.Y. – Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale [...]

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that March Biosciences has been awarded a $200,000 G-Rex® Grant. March Biosciences' G-Rex® Grant will be used to advance the manufacturing of their lead asset, MB-105, a novel investigational autologous CAR-T cell therapy targeting CD5 for patients with T-cell lymphomas. [...]

PROVIDENCE, R.I. -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, announces its achievement of ISO 9001:2015 certification. This internationally recognized standard demonstrates Nabsys' dedication to maintaining a robust and effective quality management system. The ISO 9001:2015 certification underscores Nabsys' ability to consistently deliver products and services that meet customer expectations and regulatory requirements. [...]

FREDERICK, MD. — RoosterBio, Inc., a leading supplier of adult human mesenchymal stem/stromal cells (hMSCs), highly engineered media, and bioprocess development services, today announced a new collaboration with Thermo Fisher Scientific, the world leader in serving science. This collaboration aims to accelerate the availability of new, potentially life-saving cell and exosome therapies that have the [...]

FORT MYERS, Fla. and FREMONT, Calif. -- NeoGenomics, Inc. (Nasdaq:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, Inc., a developer of a revolutionary ultra-high throughput next-generation sequencing (NGS) platform, today announced a collaboration to use Ultima's UG 100™ sequencing platform and its ppmSeq™ technology to advance NeoGenomics' ability to offer innovative clinical tests. [...]

MADISON, Wis. -- FUJIFILM Cellular Dynamics, Inc., a leading developer and manufacturer of human induced pluripotent stem cells (iPSC), today announces the appointment of Delara Motlagh, as its new chief operating officer (COO) effective immediately. In this role, Motlagh will drive the Company’s overall business and R&D strategy while leading operational execution for both domestic [...]

Quanterix Files Updated Investor Presentation Highlighting Compelling Benefits of Combination BILLERICA, Mass. and MARLBOROUGH, Mass. – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 [...]

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and cell culture services to accelerate and optimize biologics production. Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, is collaborating with Cytiva, a global life sciences leader, to provide customers with an [...]

THOUSAND OAKS, Calif. - Teledyne Technologies Incorporated (NYSE:TDY) ("Teledyne"​) announced today that Teledyne's Board of Directors named George C. Bobb III as Teledyne's President and Chief Executive Officer, effective immediately. Simultaneously, Edwin Roks has retired as Teledyne's Chief Executive Officer, but will continue as a special advisor to Robert Mehrabian, Executive Chairman, through August 31, [...]

Launched with 300 million cells and growing, Arc’s collection of computation-ready, single-cell measurements is getting a boost from 10x and Ultima technologies Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after chemical or genetic perturbations to enable “virtual cell” models and other innovations. Two months after [...]